Dr Reddys Laboratories Ltd Share Price Today - Live Blog for March 14, 2026

After a -2.02% decline, Dr Reddys Laboratories Ltd shares are now trading at 1292.30. The stock has a PE ratio of 19.5400, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares saw a -2.02% decrease, reaching a current market price of 1292.30. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.5400, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd suffered a -2.02% decline, and it currently trades at 1292.30 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd observed a -2.02% decrease in its share price, a situation that merits attention. As of now, it's actively trading at 1292.30. The stock has a PE ratio of 19.5400, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd has experienced a -2.02% drop, and it's now trading at 1292.30 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The stock of Dr Reddys Laboratories Ltd suffered a -2.02% decline, and it currently trades at 1292.30 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd's share price has fallen by -2.02%, a situation worth noting. At present, the stock is trading at 1292.30. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 19.5400, while the industry PE ratio is 32.1656.

Dr Reddys Laboratories Ltd stock price decreased by -2.02%, with the current market value at 1292.30 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

After a -2.02% decline, Dr Reddys Laboratories Ltd shares are now trading at 1292.30. The stock has a PE ratio of 19.5400, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd has experienced a -2.02% drop, and it's now trading at 1292.30 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd shares saw a -2.02% decrease, reaching a current market price of 1292.30. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.5400, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd witnessed a -2.02% drop in its share price and is currently trading at 1292.30. With the stock's PE at 19.5400 and the industry PE at 32.1656, investors are weighing their options.